Hudson Bay Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $2.73M | Sell |
|
|||||
|
2025
Q1 | $3.74M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.11M | Sell |
|
|||||
|
2024
Q1 | $1.52M | Buy |
|
|||||
|
2023
Q4 | $779K | Buy |
|
|||||
|
2023
Q3 | $460K | Buy |
|
|||||
|
2023
Q2 | $455K | Buy |
|
|||||
|
2023
Q1 | $354K | Buy |
|
|||||
|
2022
Q4 | $287K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.14M | Buy |
|
|||||
|
2018
Q4 | $1.05M | Sell |
|
|||||
|
2018
Q3 | $1.68M | Sell |
|
|||||
|
2018
Q2 | $1.72M | Sell |
|
|||||
|
2018
Q1 | $2.67M | Buy |
|